Qing Zuraw

Qing Zuraw

Former Chief Development OfficeratVor Biopharma· In the 2025 proxy

Pay in FY2025Vor Biopharma stock -41.1% the same year

Qing Zuraw was paid $11.8M in FY2025 (Dec). Vor Biopharma stock fell 41.1% that year.

Pay$100 in the stock at the end of FY24 → $59
Pay is from the Summary Compensation Table of each Vor Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Vor BiopharmaPublic company · 1 yr
    • Former Chief Development Officer2025 – Present · 1 yrStock in role +18%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?